Zilovertamab vedotin
2140-010
Phase 3 mab active
Quick answer
Zilovertamab vedotin for Diffuse Large B-Cell Lymphoma is a Phase 3 program (mab) at Merck KGaA, Darmstadt, Germany with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck KGaA, Darmstadt, Germany
- Indication
- Diffuse Large B-Cell Lymphoma
- Phase
- Phase 3
- Modality
- mab
- Status
- active